Asepsis-Medical-Logo-Web
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
Asepsis-Medical-Logo-Web
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use

Asepsis announces the USPTO Notice of Allowance for Patent Application No. 14/877,349

by Asepsis Medical
May 2, 2018
1 like

Asepsis announces the USPTO Notice of Allowance for Patent Application No. 14/877,349 encompassing the prefilled and ready to fill, Diluent-2-Dose™ syringe.


Read More… U.S. Patented Application 14/877,349 and Diluent-2-Dose™
News
PREV
NEXT

Copyright © 2022 Asepsis Medical Technologies, LLC. All rights reserved.